You can turn it around as you want, but the BioNTech share may have had a disappointing development on the…
Read More »BNT162
Yesterday, some investors on NASDAQ took profits on BioNTech shares. The minus on the closing price basis of 6.6 percent…
Read More »
BioNTech and Pfizer have already sold part of the planned production of a vaccine against SARS-CoV-2 that is currently under…
Read More »